Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells
- 1 July 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 47 (7), 1221-1230
- https://doi.org/10.1111/1440-1681.13295
Abstract
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.Keywords
Funding Information
- Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi (2017‐24579)
- Istanbul Üniversitesi
This publication has 42 references indexed in Scilit:
- Selective modulation of subtype III IP3R by Akt regulates ER Ca2+ release and apoptosisCell Death & Disease, 2012
- The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinomaCell Calcium, 2010
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Requirement of Inositol 1,4,5-Trisphosphate Receptors for Tumor-mediated Lymphocyte ApoptosisJournal of Biological Chemistry, 2008
- Caspase‐3‐truncated type 1 inositol 1,4,5‐trisphosphate receptor enhances intracellular Ca2+ leak and disturbs Ca2+ signallingBiology of the Cell, 2008
- Inositol Trisphosphate Receptor Ca2+Release ChannelsPhysiological Reviews, 2007
- Does the calcein-AM method assay the total cellular ‘labile iron pool’ or only a fraction of it?Biochemical Journal, 2007
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002